Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.
In 2019, the market size of Acute Intermittent Porphyria is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acute Intermittent Porphyria.
This report studies the global market size of Acute Intermittent Porphyria, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Acute Intermittent Porphyria production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories
...
Market Segment by Product Type
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions
Market Segment by Application
Hospitals & Clinics
Research Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Acute Intermittent Porphyria status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Acute Intermittent Porphyria manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Acute Intermittent Porphyria are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Acute Intermittent Porphyria is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acute Intermittent Porphyria.
This report studies the global market size of Acute Intermittent Porphyria, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Acute Intermittent Porphyria production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories
...
Market Segment by Product Type
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions
Market Segment by Application
Hospitals & Clinics
Research Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Acute Intermittent Porphyria status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Acute Intermittent Porphyria manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Acute Intermittent Porphyria are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type (2019-2025)
1.3.2 Gonadotropin-Releasing Hormone Analogues
1.3.3 Prophylactic Hematin Infusions
1.4 Market Segment by Application
1.4.1 Global Acute Intermittent Porphyria Market Share by Application (2019-2025)
1.4.2 Hospitals & Clinics
1.4.3 Research Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Acute Intermittent Porphyria Production Value 2014-2025
2.1.2 Global Acute Intermittent Porphyria Production 2014-2025
2.1.3 Global Acute Intermittent Porphyria Capacity 2014-2025
2.1.4 Global Acute Intermittent Porphyria Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Acute Intermittent Porphyria Market Size CAGR of Key Regions
2.2.2 Global Acute Intermittent Porphyria Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Acute Intermittent Porphyria Capacity by Manufacturers
3.1.2 Global Acute Intermittent Porphyria Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Acute Intermittent Porphyria Revenue by Manufacturers (2014-2019)
3.2.2 Acute Intermittent Porphyria Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI)
3.3 Acute Intermittent Porphyria Price by Manufacturers
3.4 Key Manufacturers Acute Intermittent Porphyria Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Acute Intermittent Porphyria Market
3.6 Key Manufacturers Acute Intermittent Porphyria Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Gonadotropin-Releasing Hormone Analogues Production and Production Value (2014-2019)
4.1.2 Prophylactic Hematin Infusions Production and Production Value (2014-2019)
4.2 Global Acute Intermittent Porphyria Production Market Share by Type
4.3 Global Acute Intermittent Porphyria Production Value Market Share by Type
4.4 Acute Intermittent Porphyria Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Acute Intermittent Porphyria Consumption by Application
6 Production by Regions
6.1 Global Acute Intermittent Porphyria Production (History Data) by Regions 2014-2019
6.2 Global Acute Intermittent Porphyria Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.3.2 United States Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Acute Intermittent Porphyria Import & Export
6.4 European Union
6.4.1 European Union Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.4.2 European Union Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Acute Intermittent Porphyria Import & Export
6.5 China
6.5.1 China Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.5.2 China Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Acute Intermittent Porphyria Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Acute Intermittent Porphyria Consumption by Regions
7.1 Global Acute Intermittent Porphyria Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Acute Intermittent Porphyria Consumption by Type
7.2.2 United States Acute Intermittent Porphyria Consumption by Application
7.3 European Union
7.3.1 European Union Acute Intermittent Porphyria Consumption by Type
7.3.2 European Union Acute Intermittent Porphyria Consumption by Application
7.4 China
7.4.1 China Acute Intermittent Porphyria Consumption by Type
7.4.2 China Acute Intermittent Porphyria Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Acute Intermittent Porphyria Consumption by Type
7.5.2 Rest of World Acute Intermittent Porphyria Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Dahaner
8.1.1 Dahaner Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Acute Intermittent Porphyria
8.1.4 Acute Intermittent Porphyria Product Introduction
8.1.5 Dahaner Recent Development
8.2 Roche
8.2.1 Roche Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Acute Intermittent Porphyria
8.2.4 Acute Intermittent Porphyria Product Introduction
8.2.5 Roche Recent Development
8.3 Bio-Rad Laboratories
8.3.1 Bio-Rad Laboratories Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Acute Intermittent Porphyria
8.3.4 Acute Intermittent Porphyria Product Introduction
8.3.5 Bio-Rad Laboratories Recent Development
8.4 Siemens
8.4.1 Siemens Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Acute Intermittent Porphyria
8.4.4 Acute Intermittent Porphyria Product Introduction
8.4.5 Siemens Recent Development
8.5 ARKRAY
8.5.1 ARKRAY Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Acute Intermittent Porphyria
8.5.4 Acute Intermittent Porphyria Product Introduction
8.5.5 ARKRAY Recent Development
8.6 Sysmex Corporation
8.6.1 Sysmex Corporation Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Acute Intermittent Porphyria
8.6.4 Acute Intermittent Porphyria Product Introduction
8.6.5 Sysmex Corporation Recent Development
8.7 ACON Laboratories
8.7.1 ACON Laboratories Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Acute Intermittent Porphyria
8.7.4 Acute Intermittent Porphyria Product Introduction
8.7.5 ACON Laboratories Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Acute Intermittent Porphyria Capacity, Production Forecast 2019-2025
9.1.2 Global Acute Intermittent Porphyria Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Acute Intermittent Porphyria Production and Value Forecast by Regions 2019-2025
9.2.2 Global Acute Intermittent Porphyria Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Acute Intermittent Porphyria Production Forecast by Type
9.7.2 Global Acute Intermittent Porphyria Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Acute Intermittent Porphyria Sales Channels
10.2.2 Acute Intermittent Porphyria Distributors
10.3 Acute Intermittent Porphyria Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type (2019-2025)
1.3.2 Gonadotropin-Releasing Hormone Analogues
1.3.3 Prophylactic Hematin Infusions
1.4 Market Segment by Application
1.4.1 Global Acute Intermittent Porphyria Market Share by Application (2019-2025)
1.4.2 Hospitals & Clinics
1.4.3 Research Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Acute Intermittent Porphyria Production Value 2014-2025
2.1.2 Global Acute Intermittent Porphyria Production 2014-2025
2.1.3 Global Acute Intermittent Porphyria Capacity 2014-2025
2.1.4 Global Acute Intermittent Porphyria Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Acute Intermittent Porphyria Market Size CAGR of Key Regions
2.2.2 Global Acute Intermittent Porphyria Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Acute Intermittent Porphyria Capacity by Manufacturers
3.1.2 Global Acute Intermittent Porphyria Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Acute Intermittent Porphyria Revenue by Manufacturers (2014-2019)
3.2.2 Acute Intermittent Porphyria Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI)
3.3 Acute Intermittent Porphyria Price by Manufacturers
3.4 Key Manufacturers Acute Intermittent Porphyria Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Acute Intermittent Porphyria Market
3.6 Key Manufacturers Acute Intermittent Porphyria Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Gonadotropin-Releasing Hormone Analogues Production and Production Value (2014-2019)
4.1.2 Prophylactic Hematin Infusions Production and Production Value (2014-2019)
4.2 Global Acute Intermittent Porphyria Production Market Share by Type
4.3 Global Acute Intermittent Porphyria Production Value Market Share by Type
4.4 Acute Intermittent Porphyria Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Acute Intermittent Porphyria Consumption by Application
6 Production by Regions
6.1 Global Acute Intermittent Porphyria Production (History Data) by Regions 2014-2019
6.2 Global Acute Intermittent Porphyria Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.3.2 United States Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Acute Intermittent Porphyria Import & Export
6.4 European Union
6.4.1 European Union Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.4.2 European Union Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Acute Intermittent Porphyria Import & Export
6.5 China
6.5.1 China Acute Intermittent Porphyria Production Growth Rate 2014-2019
6.5.2 China Acute Intermittent Porphyria Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Acute Intermittent Porphyria Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Acute Intermittent Porphyria Consumption by Regions
7.1 Global Acute Intermittent Porphyria Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Acute Intermittent Porphyria Consumption by Type
7.2.2 United States Acute Intermittent Porphyria Consumption by Application
7.3 European Union
7.3.1 European Union Acute Intermittent Porphyria Consumption by Type
7.3.2 European Union Acute Intermittent Porphyria Consumption by Application
7.4 China
7.4.1 China Acute Intermittent Porphyria Consumption by Type
7.4.2 China Acute Intermittent Porphyria Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Acute Intermittent Porphyria Consumption by Type
7.5.2 Rest of World Acute Intermittent Porphyria Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Dahaner
8.1.1 Dahaner Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Acute Intermittent Porphyria
8.1.4 Acute Intermittent Porphyria Product Introduction
8.1.5 Dahaner Recent Development
8.2 Roche
8.2.1 Roche Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Acute Intermittent Porphyria
8.2.4 Acute Intermittent Porphyria Product Introduction
8.2.5 Roche Recent Development
8.3 Bio-Rad Laboratories
8.3.1 Bio-Rad Laboratories Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Acute Intermittent Porphyria
8.3.4 Acute Intermittent Porphyria Product Introduction
8.3.5 Bio-Rad Laboratories Recent Development
8.4 Siemens
8.4.1 Siemens Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Acute Intermittent Porphyria
8.4.4 Acute Intermittent Porphyria Product Introduction
8.4.5 Siemens Recent Development
8.5 ARKRAY
8.5.1 ARKRAY Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Acute Intermittent Porphyria
8.5.4 Acute Intermittent Porphyria Product Introduction
8.5.5 ARKRAY Recent Development
8.6 Sysmex Corporation
8.6.1 Sysmex Corporation Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Acute Intermittent Porphyria
8.6.4 Acute Intermittent Porphyria Product Introduction
8.6.5 Sysmex Corporation Recent Development
8.7 ACON Laboratories
8.7.1 ACON Laboratories Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Acute Intermittent Porphyria
8.7.4 Acute Intermittent Porphyria Product Introduction
8.7.5 ACON Laboratories Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Acute Intermittent Porphyria Capacity, Production Forecast 2019-2025
9.1.2 Global Acute Intermittent Porphyria Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Acute Intermittent Porphyria Production and Value Forecast by Regions 2019-2025
9.2.2 Global Acute Intermittent Porphyria Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Acute Intermittent Porphyria Production Forecast by Type
9.7.2 Global Acute Intermittent Porphyria Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Acute Intermittent Porphyria Sales Channels
10.2.2 Acute Intermittent Porphyria Distributors
10.3 Acute Intermittent Porphyria Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
